- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Inspira Technologies: Inspira Announces 97.3% Accuracy Results for HYLA Blood Sensor, Advancing Toward FDA Submission for Clearance | 139 | GlobeNewswire (Europe) | RA'ANANA, Israel, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Inspira Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) ("Inspira," "Inspira Technologies," or the "Company"), a pioneer in innovative life-support... ► Artikel lesen | |
| Do | Inspira Technologies OXY B.H.N. Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
| Mi | Inspira Technologies OXY B.H.N. Ltd - S-8, Securities to be offered to employees in employee benefit plans | 1 | SEC Filings | ||
| 02.09. | Inspira Technologies OXY B.H.N. Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 22.08. | Inspira Technologies stock soars after receiving US patent for ART500 | 2 | Investing.com | ||
| 22.08. | Inspira Technologies receives US patent for respiratory support system | 3 | Investing.com | ||
| 22.08. | Inspira Technologies: Inspira Receives U.S. Patent Approval for the ART500 Core Technology, Key Patent Positions the Company to Dominate $20 Billion Estimated Market | 1 | GlobeNewswire (USA) | ||
| 19.08. | Inspira Technologies secures $27M order from African Ministry of Health; shares up | 2 | Seeking Alpha | ||
| INSPIRA TECHNOLOGIES OXY BHN Aktie jetzt für 0€ handeln | |||||
| 19.08. | Inspira Technologies: Inspira Secures $27 Million Government Binding Purchase Order for ART100 Systems with Full Payment in 2025 | 2 | GlobeNewswire (USA) | ||
| 19.08. | Inspira Technologies OXY B.H.N. Ltd - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 07.08. | Inspira Technologies files routine shelf registration renewal | 2 | Investing.com | ||
| 07.08. | Inspira Technologies: Inspira Clarifies Routine Nature of Registration Statement on Form F-3 Filing Performed Every Three Years | 2 | GlobeNewswire (USA) | ||
| 31.07. | Inspira Technologies: Inspira Activates U.S. Based Consulting Firm to Execute Transformational Initiatives | 1 | GlobeNewswire (USA) | ||
| 31.07. | Inspira Technologies OXY B.H.N. Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 18.07. | Inspira Technologies: Inspira Regains Compliance with Nasdaq Minimum Bid Price Requirement | 222 | GlobeNewswire (Europe) | RA'ANANA, Israel, July 18, 2025 (GLOBE NEWSWIRE) -- Inspira Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) ("Inspira," "Inspira Technologies," or the "Company"), a pioneer in innovative life-support... ► Artikel lesen | |
| 17.07. | Inspira Technologies OXY B.H.N. Ltd - 6-K, Report of foreign issuer | 3 | SEC Filings | ||
| 10.07. | Inspira Technologies: Inspira Achieves All Key Objectives in Previously Announced Government Talks, Forging a Pathway to National Adoption and Global Scale-Up of the ART100 | 5 | GlobeNewswire (USA) | ||
| 10.07. | Inspira Technologies OXY B.H.N. Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 07.07. | Inspira Technologies verhandelt mit Regierung über Einsatz von Medizintechnik in der Notfallversorgung | 3 | Investing.com Deutsch | ||
| 07.07. | Inspira Technologies: Inspira in High-Level Government Talks to Advance National Integration of the ART100 and Establish a Global Distribution Framework | 1 | GlobeNewswire (USA) |
1 2 3 Weiter >>
46 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SERNOVA BIOTHERAPEUTICS | 0,109 | -2,68 % | Sernova Corp.: Sernova Biotherapeutics to Participate in the H.C. Wainwright 27th Annual Global Investor Conference | ||
| ATOSSA THERAPEUTICS | 0,700 | -2,10 % | Atossa Genetics stock rating reiterated by H.C. Wainwright on FDA meeting plans | ||
| PING AN HEALTHCARE | 2,523 | +3,32 % | Ping An Healthcare and Technology Company Limited: Ping An Good Doctor (1833.HK) Reports Solid Interim Results with Steady Revenue and Profit Growth | HONG KONG, Aug. 20, 2025 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited (the "Company"; Stock Code: 1833.HK) announced its interim results for the six months ended June... ► Artikel lesen | |
| MOUNTAIN VALLEY MD | 0,011 | -13,64 % | Mountain Valley MD Holdings Inc: Mountain Valley appoints Batchelor as director | ||
| CO-DIAGNOSTICS | 0,300 | +1,35 % | Co-Diagnostics, Inc. Reports Second Quarter 2025 Financial Results | SALT LAKE CITY, Aug. 14, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development... ► Artikel lesen | |
| VERU | 3,490 | -1,97 % | Veru Inc.: Veru Reports Fiscal 2025 Third Quarter Financial Results and Clinical Program Progress | --Company reported positive efficacy and safety data from Phase 2b QUALITY study showing enobosarm added to semaglutide led to preservation of muscle, greater fat loss, and fewer gastrointestinal... ► Artikel lesen | |
| CYTOSORBENTS | 0,787 | -0,88 % | CytoSorbents bei H.C. Wainwright: Strategisches Wachstum und regulatorische Herausforderungen | ||
| TEMPEST THERAPEUTICS | 6,010 | -100,00 % | Tempest Therapeutics: Tempest Reports Second Quarter 2025 Financial Results and Provides Business Update | Received clearance to proceed with pivotal trial of amezalpat combination therapy for first-line hepatocellular carcinoma (HCC) in ChinaGranted orphan drug designation from the European Medicines... ► Artikel lesen | |
| VOLITIONRX | 0,641 | +1,47 % | H.C. Wainwright bestätigt Kaufempfehlung für VolitionRX nach Partnerschaft mit Werfen | ||
| EKSO BIONICS | 3,855 | -1,66 % | Ekso Bionics Holdings, Inc.: Ekso Bionics Reports Second Quarter 2025 Financial Results | SAN RAFAEL, Calif., July 28, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) ("Ekso Bionics" or the "Company"), an industry leader in exoskeleton technology for medical and industrial... ► Artikel lesen | |
| IMUNON | 4,800 | +4,80 % | Imunon, Inc.: IMUNON Successfully Regains Compliance with Nasdaq Minimum Bid Price Listing Requirement | LAWRENCEVILLE, N.J., Aug. 28, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage company in Phase 3 development of its DNA-mediated immunotherapy, today announced that the Company... ► Artikel lesen | |
| BEYOND AIR | 2,450 | +8,41 % | Beyond Air, Inc. - 8-K, Current Report | ||
| AVINGER | 0,465 | -22,17 % | NSE - Avinger Inc - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | ||
| NOVACYT | 0,490 | +5,83 % | Novacyt subsidiary fined for HSE breach at 'historical operation' | ||
| AROVELLA THERAPEUTICS | 0,042 | +2,47 % | AROVELLA THERAPEUTICS LIMITED: 2025 ESG Report |
INSPIRA TECHNOLOGIES OXY BHN LTD gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell +3,88 % bei einem Aktienkurs von 1,205 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu INSPIRA TECHNOLOGIES OXY BHN LTD finden Sie auf Wallstreet Online.